The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS - Related Studies

The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS

This study has been completed.

Study NCT00000717. Last updated on June 23, 2005. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pneumonia, Pneumocystis Carinii
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Infection
		Pneumonia
		Pneumonia, Pneumocystis

3	More general conditions related to this trial
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Lung Diseases
		Lung Diseases, Fungal
		Mycoses
		Pneumocystis Infections
		Respiratory Tract Diseases
		Respiratory Tract Infections
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Primaquine
		Clindamycin

5	Additional drug interventions recognized in this trial
		Clindamycin-2-phosphate

6	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antimalarials
		Antiparasitic Agents
		Antiprotozoal Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Protein Synthesis Inhibitors
		Therapeutic Uses

7	Sponsors listed in this trial
		National Institute of Allergy and Infectious Diseases (NIAID)